Fundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines
Autor Rebecca Sheetsen Limba Engleză Paperback – dec 2017
- Provides a broad overview and introduction to the regulatory processes, from product development pathways, through clinical trials and product development stages and beyond
- Includes FDA, EMA, ICH, and WHO recommendations and guidelines so readers can compare and contrast the different regulatory regions with their expectations and understand why they are different
- Contains chapters on some of the exceptions to the process including how biosimilars and in vitro diagnostics are regulated
- Includes numerous case studies, learning activities, and real-world examples across several classes of biotechnological products
Preț: 722.68 lei
Preț vechi: 881.31 lei
-18% Nou
Puncte Express: 1084
Preț estimativ în valută:
138.31€ • 143.66$ • 114.88£
138.31€ • 143.66$ • 114.88£
Carte tipărită la comandă
Livrare economică 27 ianuarie-10 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128092903
ISBN-10: 0128092904
Pagini: 450
Dimensiuni: 191 x 235 x 27 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 0128092904
Pagini: 450
Dimensiuni: 191 x 235 x 27 mm
Editura: ELSEVIER SCIENCE
Public țintă
Graduate students and professors in biotechnology, pharmaceutical science and regulatory science programs, regulatory officials, industry professionalsCuprins
Section I: Regulatory Process1. Introduction2. Discovery and Development of Biologicals3. International Harmonization4. Pre-IND Profess, Guidance from Regulators in Advance of a Clinical Trials Application5. Clinical Trials Approvals and Investigational New Drug Applications6. Marketing Authorization Processes7. Special Regulatory Programs8. Post-Marketing Changes to an Approved Application or Variations9. Compliance and Inspections10. Good "X" Practices
Section II: Regulatory Science11. Preclinical Safety and Toxicology12. Preclinical Proof-of-Concept and Pharmacology, Animal Use Ethics13. Genetically Modified Organisms and Institutional Biosafety Committees14. Risk Assessments15. Chemistry, Manufacturing, and Controls Information (CMC) and Process Validation16. Analytics, Analytical Validation, Lot Release, and National Control Laboratories17. Regulatory Aspects of Clinical Trials18. Ethics of Clinical Trials and the Informed Consent Process19. Institutional Review Board Processes (Ethics Committees)20. Biosimilars21. In Vitro Diagnostics22. Regulatory Policy and Public Health Policy
Section II: Regulatory Science11. Preclinical Safety and Toxicology12. Preclinical Proof-of-Concept and Pharmacology, Animal Use Ethics13. Genetically Modified Organisms and Institutional Biosafety Committees14. Risk Assessments15. Chemistry, Manufacturing, and Controls Information (CMC) and Process Validation16. Analytics, Analytical Validation, Lot Release, and National Control Laboratories17. Regulatory Aspects of Clinical Trials18. Ethics of Clinical Trials and the Informed Consent Process19. Institutional Review Board Processes (Ethics Committees)20. Biosimilars21. In Vitro Diagnostics22. Regulatory Policy and Public Health Policy